Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of Neuroimmunology
|
February 16, 2000
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
A B Heimberger, L E Crotty, G E Archer, et al.
Blood
|
February 27, 2001
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
M H Tomasson, I R Williams, S Li, et al.
Cancer Gene Therapy
|
December 31, 1997
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells
U Herrlinger, C M Kramm, K M Johnston, et al.
Immunity
|
March 11, 1999
Cathepsin S required for normal MHC class II peptide loading and germinal center development
G P Shi, J A Villadangos, G Dranoff, et al.
The Journal of Clinical Investigation
|
February 12, 1998
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy
J L Schultze, S Michalak, M J Seamon, et al.
The Journal of Clinical Investigation
|
September 7, 2000
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
C J Wu, X F Yang, S McLaughlin, et al.
Blood
|
February 3, 1998
Involvement of interleukin-3 in delayed-type hypersensitivity
N Mach, C S Lantz, S J Galli, et al.
Science (New York, N.Y.)
|
April 29, 1994
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
G Dranoff, A D Crawford, M Sadelain, et al.
Blood
|
July 1, 1996
A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus
C Champseix, V Maréchal, I Khazaal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia
X F Yang, C J Wu, S McLaughlin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of Neuroimmunology
|
February 16, 2000
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
A B Heimberger, L E Crotty, G E Archer, et al.
Blood
|
February 27, 2001
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
M H Tomasson, I R Williams, S Li, et al.
Cancer Gene Therapy
|
December 31, 1997
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells
U Herrlinger, C M Kramm, K M Johnston, et al.
Immunity
|
March 11, 1999
Cathepsin S required for normal MHC class II peptide loading and germinal center development
G P Shi, J A Villadangos, G Dranoff, et al.
The Journal of Clinical Investigation
|
February 12, 1998
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy
J L Schultze, S Michalak, M J Seamon, et al.
The Journal of Clinical Investigation
|
September 7, 2000
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
C J Wu, X F Yang, S McLaughlin, et al.
Blood
|
February 3, 1998
Involvement of interleukin-3 in delayed-type hypersensitivity
N Mach, C S Lantz, S J Galli, et al.
Science (New York, N.Y.)
|
April 29, 1994
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
G Dranoff, A D Crawford, M Sadelain, et al.
Blood
|
July 1, 1996
A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus
C Champseix, V Maréchal, I Khazaal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia
X F Yang, C J Wu, S McLaughlin, et al.
Page
of 6